Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study-Reference-Cited by-同舟云学术

Randomized comparison of Zotarolimus-Eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: Rationale, design, and characterization of the patient population for the Zotarolimus-eluting Endeavor Sprint stent in Uncertain DES Candidates study

Published:2013-11 Issue:5 Volume:166 Page:831-838
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Valgimigli Marco,Patialiakas Athanasios,Thury Attila,Colangelo Salvatore,Campo Gianluca,Tebaldi Matteo,Ungi Imre,Tondi Stefano,Roffi Marco,Menozzi Alberto,de Cesare Nicoletta,Garbo Roberto,Meliga Emanuele,Testa Luca,Gabriel Henrique M.,Airoldi Flavio,Ferlini Marco,Liistro Francesco,Dellavalle Antonio,Vranckx Pascal,Briguori Carlo

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference23 articles.

1. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial;Valgimigli;JAMA,2008

2. Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents;Kastrati;N Engl J Med,2007

3. Effectiveness and safety of drug-eluting stents in Ontario;Tu;N Engl J Med,2007

4. Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY);Valgimigli;Int J Cardiol,2013

5. Zotarolimus (ABT-578) eluting stents;Burke;Adv Drug Deliv Rev,2006

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sex-Related Differences in the Bleeding Trade-Off for Patients Undergoing Percutaneous Coronary Intervention;Circulation: Cardiovascular Interventions;2021-09

2. Three-year major clinical outcomes of phosphorylcholine polymer- vs biolinx polymer-zotarolimus-eluting stents;Medicine;2019-08

3. Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1 month of dual antiplatelet therapy;American Heart Journal;2019-08

4. Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study;American Heart Journal;2019-03

5. Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates;International Journal of Cardiology;2019-02